Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients

Strong prognostic biomarkers are lacking regarding the stratification of treatment and surveillance regimens in head and neck squamous cell carcinoma (HNSCC). The study aimed to assess the prognostic value of soluble urokinase-type plasminogen activator receptor in plasma (suPAR) compared to evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Risør, Louise Madeleine, Binderup, Tina, Fosbøl, Marie Øbro, Andersen, Kim Francis, Loft, Annika, Friborg, Jeppe, Kjaer, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645757/
https://www.ncbi.nlm.nih.gov/pubmed/36352036
http://dx.doi.org/10.1038/s41598-022-21175-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645757/
https://www.ncbi.nlm.nih.gov/pubmed/36352036
http://dx.doi.org/10.1038/s41598-022-21175-7

Ejemplares similares